Tilray Officially Announces Pricing for NASDAQ IPO

Tilray, Inc., wholly owned subsidiary of private company Privateer Holdings, Inc., has officially announced this week pricing on its NADAQ initial public offering of the company’s stock.

Tilray is a global medicinal cannabis researcher, cultivator, processor, and distributer of finished product. The company prides itself on its vertically integrated business model and scientifically driven manufacturing techniques. The company sells a number of different products that include THC, CBD, and a blend of both cannabinoids in the form of cannabis flower and other extracts.

The company will offering 9,000,000 shares of Class 2 common stock. 6,524,000 will be sold in the U.S. and 2,476,000 shares to be sold in Canada at $17.oo a share. Based on the exchange rate between the two countries Tilray expects the IPO to raise the company a total of  US$153,000,000.00

Tilray will begin trading on the Nasdaq Global Market Exchange under the ticker symbol TLRY. The company has successfully completed its registration statement on Form S-1 and the SEC has approved the offering. Cowen and BMO Capital Markets are acting jointly as book-runners for the IPO.

Related posts

Isodiol and Level Brands Inc. CEO Kathy Ireland to Launch 3 New CBD Products

Editor

420 Real Properties- Licensed, Legal & Profitable Cultivation, Manufacturing & Distribution Facility in Adelanto, CA

Editor

GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA)

Editor

Leave a Comment

%d bloggers like this: